文章引用说明 更多>> (返回到该文章)

O’rien, S.G., Guilhot, F., Goldman, J.M., et al. (2008) In-ternational Randomized Study of Interferon Reigns STl571 (IRIS) 7-Year Follow-Up: Sustained Survival, Low Rate of Transformation and Increased Rate of Major Molecular Response (MMR) in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Imatinib (IM). Blood, 112, abstr 186.

被以下文章引用:

在线客服:
对外合作:
联系方式:400-6379-560
投诉建议:feedback@hanspub.org
客服号

人工客服,优惠资讯,稿件咨询
公众号

科技前沿与学术知识分享